C00-C97
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients are eligible if they have / are • signed the written informed consent to participate in the study • a primary diagnosis of o gynaecological cancer o bladder cancer o colorectal cancer o testicular cancer o prostate cancer o breast cancer o sarcoma and o lymphoma • Female patients > 18 years to 42 years • Female patients in pre-menopause • Male patients > 18 years • Patients in any treatment with curative intention affecting fertility, focusing on o Surgery o Systemic therapy o Radiotherapy o Combined therapy (radiation, surgery, systemic treatment)
Exclusion criteria
Exclusion criteria: Patients with other than the above mentioned diagnoses and treatments, that are contradictionnairy to the inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Development of a stand-alone questionnaire in accordance with the EORTC QLG guideline. | — |
Countries
Austria, Germany, Netherlands, Poland, Portugal, Serbia, Spain, United Kingdom
Contacts
Interdisziplinäres Tumorzentrum - CCCF - Stiftungsprofessur Selbsthilfeforschung